SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-288430
Filing Date
2011-10-31
Accepted
2011-10-31 14:26:11
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d235747d10q.htm 10-Q 823010
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d235747dex311.htm EX-31.1 9557
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d235747dex312.htm EX-31.2 9547
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d235747dex321.htm EX-32.1 3488
  Complete submission text file 0001193125-11-288430.txt   7287682

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bmrn-20110930.xml EX-101.INS 1524056
6 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20110930.xsd EX-101.SCH 51015
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20110930_cal.xml EX-101.CAL 80217
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20110930_def.xml EX-101.DEF 133278
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20110930_lab.xml EX-101.LAB 385760
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20110930_pre.xml EX-101.PRE 303610
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 111167810
SIC: 2834 Pharmaceutical Preparations